Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-16

FDA Approved: QUTENZA — Original Application (Averitas Pharma Inc)

View source ↗

Summary

FDA approved QUTENZA (capsaicin) 8% patch from Averitas Pharma Inc in its original application for the treatment of postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

ORIG AP for QUTENZA (CAPSAICIN)